Patients treated with an optimal treatment plan have 10% probability of experiencing treatment failure in terms of local recurrence or severe treatment related toxicity. In patients with suboptimal treatment plans the risk for treatment failure doubles. More, impact of dose volume constraints on the clinical results suggests that the highest priority in treatment planning should be given to reach the planning aims for the target dose coverage. . Different clinical and dosimetric parameters were analyzed and compared between patients with RD and those with CR. Results: We observed 18 (45%) patients with CR and 22 (55%) patients with RD. In univariate analysis, patients with RD had a significantly longer overall treatment time than those with CR (59.5 vs 53 days, p = 0.0321). The D90 value for the highrisk CTV (HR-CTV) was higher in the group with CR than in the group with RD (65.9 vs 64.2Gy α/β=10 , p = 0.0439). In multivariate analysis, overall treatment time remained the only predictive factor for CR (p = 0.033), even if the difference for D 90 HR-CTV kept a trend toward significance (p = 0.057). Conclusions: This study showed that tumor sterilization is significantly correlated with overall treatment time and probably with cumulative dose delivered to the HR-CTV. These results emphasize the attention that must be given to treatment organization and dosimetry optimization. We developed a scintillator fiber optic dosimeter in two configurations suitable for both LDR and HDR prostate brachytherapy comprising two disposable probes adapted to both modalities. LDR typically uses low energy emitters (< 50 keV) and for that reason a high sensitivity device is required. Our detector uses a 5mm scintillating fiber optic optically coupled to a fiber optic waveguide with a silicon photomultiplier (SiPM) for light readout. SiPMs are solid-state devices, comprising multiple pixels that behave as Geiger-mode avalanche photodiode detectors individually. These devices allow the development of lower cost dosimetric devices but because they present a characteristic dark noise, we developed a patented solution to overcome this issue.
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Purpose/Objective: An ideal dosimeter for prostate brachytherapy should present high sensitivity, no dependencies on beam parameters, real-time and in-vivo dose measurement, independence of dose rate and temperature, dose linearity, tissue equivalence, be easy to use and calibrate, detectable in the anatomic volume to check its position, not expensive and with disposable use of its implantable part. Organic scintillating materials have been used for radiation detection for decades. Despite of the low density of these materials, their fast response and near water equivalence make them suitable for in-vivo and real-time dosimetry. We evaluated the performance of these materials under regimes such as the ones found in prostate Low Dose Rate (LDR) and High Dose Rate (HDR) brachytherapy. We developed a scintillator fiber optic dosimeter in two configurations suitable for both LDR and HDR prostate brachytherapy comprising two disposable probes adapted to both modalities. LDR typically uses low energy emitters (< 50 keV) and for that reason a high sensitivity device is required. Our detector uses a 5mm scintillating fiber optic optically coupled to a fiber optic waveguide with a silicon photomultiplier (SiPM) for light readout. SiPMs are solid-state devices, comprising multiple pixels that behave as Geiger-mode avalanche photodiode detectors individually. These devices allow the development of lower cost dosimetric devices but because they present a characteristic dark noise, we developed a patented solution to overcome this issue. On the other hand, HDR uses radiation with energies above the Cherenkov threshold for organic materials. This means that a blue light is present as a form of noise when a charged particle travels through the medium with a velocity higher than the velocity of light in that material.
Materials and Methods:
The scintillating fiber optic used is a BCF-12 (Saint-Gobain) optically coupled to a PMMA 1 mm core fiber optic (Avago Techonologies). The SiPM used is a 1mm 2 Multi-Pixel Photon Counter (MPPC) from Hamamatsu. Results: The dosimeter shows a linear response with dose and is capable of detecting mGy dose variations like an ionization chamber. Besides fulfilling all the requirements for a dosimeter in brachytherapy, the high sensitivity of this device makes it a suitable candidate for application in LDRbrachytherapy. Energy linearity for energies below 50 keV using monochromatic x-ray photons will be presented. Conclusions: Clinical in-vitro tests were performed in collaboration with two Portuguese public hospitals and results from both LDR and HDR studies will be presented. areas included eyelid (1), nasal dorsum (7), pre auricular region (1), forehead (2) and cheek (1). The planning method was identical to all lesions, although two different immobilization techniques were applied, depending on the size and location of the lesion. The first technique was applied in facial lesions (11) and large lesions of the thorax (4): first the lesion was delineated with a radiopaque marker, followed by the immobilization of the patient with a thermoplastic mask, then one bolus plaque of 2 mm thickness was applied above the mask and the plastic catheters were placed and immobilized with two bolus plaques. The second technique was applied in small central lesions of the thorax (2) and in the eyelid: after the delineation of the lesion with a radiopaque marker, bolus plaques were placed directly above and the plastic catheters were placed and immobilized with two bolus plaques. In these cases, the limits of the mold were tattooed in the patient for reproducibility between fractions. The distance between catheters was always 10 mm. A planning CT with 1,25 (facial) and 2,5 mm (thoracic) slice thickness was acquired. The treatment planning was developed by the treatment planning system (TPS) Oncentra MasterPlan v4.1 taking into account the prescription points, dose to the skin and doses to the organs at risk (OAR). The dose was prescribed to points at 0 (eyelid) and 3 mm depth. All patients were treated by a microSelectron v3 (Elekta) that used a 192 Ir source. Eye protectors were used when necessary and the standard fractionation was 40 Gy in 10 fractions twice weekly. Dosimetric plans were analyzed for the following parameters: dose to the OAR, dose to the skin and dose to the prescribing points. The QA procedure was done using mosfets and gafchromic films. Results: The doses to the OAR were converted to Biologically Effective Dose (BED) and were always under their maximum tolerance dose. The dose verification results were accepted within a range of 10 % deviation of the planned dose to the prescribing points and to the skin.
EP-1604 HDR plesiotherapy in skin lesions
Conclusions:
This technique showed to be a viable option to facial and thoracic skin lesions. Due to the steep dose gradient of the 192 Ir sources used in brachytherapy, adjacent healthy tissue and deep structures are spared to irradiation. Furthermore, as masks and applicators are flexible, it is possible to treat lesions in irregular or curved surfaces assuring catheter fixation and treatment reproducibility between fractions.
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